Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 3NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Other solid neoplasm 2

Conditions

Carcinoma, Non-Small-Cell Lung 16Lung Neoplasms 15Breast Neoplasms 4Sarcoma 2Rhabdomyosarcoma 2Prostatic Neoplasms 2Mesothelioma, Malignant 2Hodgkin Disease 2Adenocarcinoma of Lung 2Unspecified Adult Solid Tumor, Protocol Specific 1Rhabdomyosarcoma, Embryonal 1Rhabdomyosarcoma, Alveolar 1Recurrence 1Ovarian Neoplasms 1Neoplasms 1Malignant mesenchymal tumor 1Fatigue 1Breast Neoplasms, Male 1

Interventions

Cisplatin 12Pemetrexed 6Radiotherapy 5Platinum 4Doxorubicin 41,2-diaminocyclohexaneplatinum II citrate 4cediranib 3Mitomycin 3Gemcitabine 3Decitabine 3pembrolizumab 2Vinorelbine 2SS1(dsFv)PE38 2Interferon-gamma 2Gene Expression Profiling 2Erlotinib Hydrochloride 2Depsipeptides 2Cyclophosphamide 2Celecoxib 2sargramostim 1rilotumumab 1ranpirnase 1methoxyamine 1entinostat 1decitabine and cedazuridine drug combination 1cixutumumab 1belinostat 1atezolizumab 1anetumab ravtansine 1alvocidib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Mesothelioma, Malignant × Vinorelbine × Clear all
NCT00030459 2013-08-07

Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma

National Cancer Institute (NCI)

Phase 2 Unknown
Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT00075699 2013-08-07

Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma

National Cancer Institute (NCI)

Phase 3 Completed
840 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡